Applied Therapeutics (APLT) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 9, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of Teena Lerner as director is up for shareholder vote, with board recommending approval.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year 2025 is proposed.

• Advisory vote on executive compensation and on the frequency of future say-on-pay votes are included.

• Proposal to amend the certificate of incorporation to allow a reverse stock split at a ratio between 1-for-5 and 1-for-40, at board discretion.

• Authorization to adjourn the meeting if more time is needed to solicit votes for the reverse stock split.

Board of directors and corporate governance

• Board recommends all proposals, including director election and auditor ratification.